ArticleExperimental and therapeutic medicine2016

Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.

Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.